We next examined the expression of FKBP51 and FKBP52 using The Cancer Genome Atlas (TCGA) Pan‐Cancer dataset (9858 samples) and found that the expression of FKBP51 was highest in prostate cancer, among various cancers (Fig. 8A). Here, FKBP4 is linked to cancer.